The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Bangkok Genomics Innovation PCL's Dividend Payout Ratio for the
months ended in Dec. 2025 was 0.00.
The historical rank and industry rank for Bangkok Genomics Innovation PCL's Dividend Payout Ratio or its related term are showing as below:
BKK:BKGI'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.66 Med: 0.66 Max: 0.67
Current: 0.67
During the past 7 years, the highest Dividend Payout Ratio of Bangkok Genomics Innovation PCL was 0.67. The lowest was 0.66. And the median was 0.66.
BKK:BKGI's Dividend Payout Ratio is ranked worse than 59.26% of 54
companies
in the Medical Diagnostics & Research industry
Industry Median: 0.49
vs BKK:BKGI: 0.67
During the past 7 years, the highest Trailing Annual Dividend Yield of Bangkok Genomics Innovation PCL was 4.03%. The lowest was 2.36%. And the median was 3.43%.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Bangkok Genomics Innovation PCL (BKK:BKGI) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Bangkok Genomics Innovation PCL Dividend Payout Ratio Related Terms
Bangkok Genomics Innovation PCL Dividend Payout Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bangkok Genomics Innovation PCL Dividend Payout Ratio Chart
BKK:BKGI vs TMO, DHR, IDXX: Dividend Payout Ratio Comparison
For the Diagnostics & Research subindustry, Bangkok Genomics Innovation PCL's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bangkok Genomics Innovation PCL Dividend Payout Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Bangkok Genomics Innovation PCL's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Bangkok Genomics Innovation PCL's Dividend Payout Ratio falls into.
Bangkok Genomics Innovation PCL Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bangkok Genomics Innovation PCL (BKK:BKGI) has a Dividend Payout Ratio of 0.00 as of Dec. 2025. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Bangkok Genomics Innovation PCL and its competitors. Over the past decade, Bangkok Genomics Innovation PCL's Dividend Payout Ratio has ranged from 0.66 to 0.67. According to the industry distribution chart, Bangkok Genomics Innovation PCL ranks #32 out of 54 companies in the Medical Diagnostics & Research industry, placing it in the top 59.3%.
Is Bangkok Genomics Innovation PCL's Dividend Payout Ratio too high?
Bangkok Genomics Innovation PCL's current Dividend Payout Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.66 to a high of 0.67. Based on the distribution chart, Bangkok Genomics Innovation PCL ranks #32 out of 54 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Bangkok Genomics Innovation PCL has a GF Score™ of 45/100, reflecting its overall financial health beyond just this single metric.
How does Bangkok Genomics Innovation PCL's Dividend Payout Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Bangkok Genomics Innovation PCL ranks #32 out of 54 companies for Dividend Payout Ratio. This places Bangkok Genomics Innovation PCL in the lower half of its industry. The industry median Dividend Payout Ratio is 0.49. Historically, Bangkok Genomics Innovation PCL's own Dividend Payout Ratio has ranged from 0.66 to 0.67 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Medical Diagnostics & Research company?
The median Dividend Payout Ratio among Medical Diagnostics & Research companies is 0.49, based on 54 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Bangkok Genomics Innovation PCL and its competitors. For the Medical Diagnostics & Research industry, the median Dividend Payout Ratio is 0.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bangkok Genomics Innovation PCL's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bangkok Genomics Innovation PCL stock overvalued right now?
Bangkok Genomics Innovation PCL (BKK:BKGI) has a current Dividend Payout Ratio of 0.00. The current Dividend Payout Ratio is 0.00. Bangkok Genomics Innovation PCL's overall GF Score™ is 45/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Bangkok Genomics Innovation PCL (BKK:BKGI), the current Dividend Payout Ratio is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Bangkok Genomics Innovation PCL Business Description
Bangkok Genomics Innovation PCL operate a laboratory and provide medical analysis services. Its services includes Screening for genetic abnormalities in reproductive health (Reproductive Health Testing Services),Infectious Disease Analysis Product Group (Infectious - Related Testing Services), Other screening product groups (Other Testing Services), providing technology services (Tech Solution Services), and Sales of other medical products Related (Medical - Related Products). Its segments include Sale of laboratory reagents and related products; Testing and analysis services, which derives maximum revenue; and Sale and advanced therapy medicinal product.
45GF Score
Get the complete analysis for BKK:BKGI
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:BKGI has been successfully added to your 
